Application

17226866 · USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19

Filed 2021-04-09 · Abandoned The official file ↗ · Art unit 1646 · Examiner Brittney Erin Donoghue Typical · CPC C12N 15/115 · Idera Pharmaceuticals, Inc. · Morgan, Lewis & Bockius LLP (PH)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

22.9 mo

to disposition 30.1 mo

Statutes raised

102 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.